Trades on 1 secondary market

Bioage Labs

BioAge Labs (Nasdaq ticker BIOA) is a clinical-stage biopharmaceutical company based in Emeryville, California, developing therapies that target the biology of human aging to treat metabolic diseases such as obesity and its related conditions. Its proprietary discovery platform mines longitudinal hu

minimal 11.2 / 100 0 APIs View provider profile →
CompanyBiotechnologyPharmaceuticalsLongevityAgingMetabolic Disease

Bioage Labs is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.